Patients taking Zepbound, which contains a GLP-1 agonist, may be at higher risk of developing NAION
The difference is small because elimination is logarithmic, not linear
At 40 weeks, all three doses (3 mg, 12 mg, 36 mg) of orforglipron achieved the primary endpoint of superior A1C reduction
The costs have gone up but unfortunately some of the insurance companies and the Pharmacy Benefit Networks dont want to pay that extra cost, so we are losing money by dispensing these medications. Sappidi says it can cost them anywhere between $100 and $250 for each prescription he fills of these GLP 1 medications and they dont always make that money back
Its crucial to note that the warning is based on rodent studies, and the same risk has not yet been identified in humans
Liquid L-Carnitine for Daily Energy & Metabolism Support